Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.

E StretzE M OppelH-C RäwerR ChatelainS MastnikB PrzybillaFranziska Ruёff

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2017)

Combining a temporary omalizumab therapy with an elevated maintenance dose seems a promising approach to achieve a tolerance of treatment in patients with a recurrent SAR to VIT.

Keyphrases

early onset
emergency department
mesenchymal stem cells
drug induced
replacement therapy
atopic dermatitis